Clinical Trial Update: To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of phase 2 and phase 3 studies evaluating the efficacy and safety of oral NA-921 (Bionetide) in girls and wome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• NA-921 (Bionetide) (NA-921)

Snippet

Sponsor: Biomed Industries, Inc. | Conditions: Rett Syndrome | Phase 2, Phase 3 | Status: COMPLETED